Preventing Cross-Infection of Patients with Antimicrobial Basin Liners
Can't see this email? View it online
   
  January 23, 2019  
  Infectious Diseases  
  The latest infectious diseases news from News Medical  
 

#ALT# Preventing Cross-Infection of Patients with Antimicrobial Basin Liners

Specifically designed and manufactured with the intention of preventing cross-infection of patients in clinical settings, the PathAguard® Antimicrobial Basin and Liner System (ABLiS®) works via physical means. It utilizes the unique antimicrobial properties of silver ions which have been proven to kill many microorganisms, especially those associated with hospital-acquired infections.

Find Out More Here
 
 
    KeysightMeasuring Drug Concentration in Serum - Evaluating Assay Designs
 
Pharmacokinetics (PK) is a branch of science committed to the quantitative analysis of absorption, distribution, metabolism, and excretion of drug molecules within the body of a living organism. In all clinical and pre-clinical studies, serum drug concentrations are measured at different points following drug administration, both in human patients and in animals. The outcome is a significant indicator of the pharmacokinetic properties of the drug and is pertinently relevant to dosing recommendations.
 
Learn More
 
 
   Scientists explore bacterial immunity to better understand infectious diseaseScientists explore bacterial immunity to better understand infectious disease
 
Patients with cystic fibrosis are often infected by pseudomonas aeruginosa, a bacterium that infects the lungs and prevents breathing, often causing death.
 
 High fat reduces efficiency of the immune system to fight infectious disease
 
High fat reduces efficiency of the immune system to fight infectious diseaseAPC Microbiome Ireland scientists based at University College Cork have shown for the first time that a high fat "western" diet reduces the efficiency of the immune system to fight infectious disease particularly in the gut, and to infection with the foodborne pathogen, Listeria monocytogenes.
 
 
 Many cancer patients have undiagnosed hepatitis
 
Many cancer patients have undiagnosed hepatitisA new report has described an alarmingly high rate of undiagnosed acute and chronic hepatitis B and hepatitis C in patients with cancer.
 
 
 New study compares performance of real-time infectious disease forecasting models
 
New study compares performance of real-time infectious disease forecasting modelsIn what the authors believe is the first documented comparison of several real-time infectious disease forecasting models by different teams across many seasons, five research groups report this week that a majority of models consistently showed higher accuracy than historical baseline models.
 
 
 Hepatitis C-infected patients with a history of liver cancer can be treated with antivirals
 
Hepatitis C-infected patients with a history of liver cancer can be treated with antiviralsA large, multi-center study refutes earlier suggestions that antiviral drugs for treating hepatitis C may lead to a higher recurrence of liver cancer.
 
 
 Study finds specific function of HIV protein that slows viral spread in early stages of infection
 
Study finds specific function of HIV protein that slows viral spread in early stages of infectionA study from a Massachusetts General Hospital research team has identified the specific function of a protein found in HIV and related viruses that appears to slow down viral spread in the earliest stages of infection.
 
 
 Combination therapy shows high efficacy in treating people with leishmaniasis and HIV
 
Combination therapy shows high efficacy in treating people with leishmaniasis and HIVThe results of clinical trials conducted in Ethiopia by the Drugs for Neglected Diseases initiative, in partnership with Médecins Sans Frontières, the University of Gondar, and Addis Ababa University, open the way for more effective and safer treatments for people with both HIV and visceral leishmaniasis, a group of patients who have historically suffered from poor treatment options.
 
 
 New findings challenge existing strategies for fighting infectious diseases and germs
 
New findings challenge existing strategies for fighting infectious diseases and germsDo the same laws of biodiversity which apply in nature also apply to our own bodies and homes? If so, current hygiene measures to combat aggressive germs could be, to some extent, counterproductive.